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~ U s s  of a Percutaneous Trensvalvar Axial Pump 
for Left Ventdcular Assistance During High Risk 
Angioplasty 
Philip Urban, Pascal Chatelain, Jean Pierre Ki[=isch, Emmanuel Moraedini, 
Vifali Verine, W~lhelm Rutishauser. University Hospital, Geneva, Switzerland 
Po~: left ventficular function is a dsk factor for major complications during 
PTCA. We used a now 14 French transvaivar pump system (Hemopump ,,R 
Medtrontc DLP) to support LV function during PTCA in 8 patients. 
Mean patient age was 71 :E 8 years, 5 (63%) were woman, median LVEF 
was 29% (17-67%), and all had multivessa! disease and class ifi or IV angina. 
Median heart failure class was II (I to IV). After successful percutaneous 
placement of the hemopump in all cases, maen wedge pressure dropped 
from 18 :E 8 to 15 =i: 9 mmHg (p < 0.05) and mean CI rose from 2.0 :t: 0.2 to 
2.3 ± 0.4 I/miNm2 (NS). Target vessels were 1 unprotected left main stem, 7 
native coronary branches, and 4 vein grefts. Stent implantation was used in 3 
patients. Pump function was lifesaving on two occasions (Isshemla-induced 
EMD in one oaso, and air embolism due to balloon rupture in another,L 
After a median of 2 hours (range 1 to 6 hours), the pump and introducer were 
reldeved, and hemostaais was obtained by extemal compression. There was 
no in-hospital death, myocardial infarction, need for CABG, major hematoma, 
or significant hemolysis. Two patients required blood transfusions. After a 
median follow-up of 5 months (1-15) there had been I heart failure death. 
None of the sundvors had angina symptoms, and median NYHA heart failure 
class was I (~ to III). Sh.~rt term L'se of the pereuteneous Hemopump in the 
catheterization ~aberatory is associated with only very limited compticatione. 
It effectively supports the systemic irculation and thus appears to increase 
the safety of high dsk PTCA procedu,as. 
~ Effects of cardlomyoplssty on Right Ventdcular 
Diastolic Filling During Volume Loading 
Yoshiya Toyoda, Masayoshi Okada, Mohammed A. Kashem, 
Takuro Tsukube, Tomdichire Mukal. Kobe University School of Medicine, 
Kobe, Japan 
Dynamic cardiomyoplasty (CMP) is currently under investigation. Although 
some clinical and experimental studies have dernonstra~ed improved ven- 
tricular systolic function, CMP may impair ventdcular diastolic function by its 
pericardial constraint. Perioardiai influences are more pronounced in the right 
ventriole as compared with the left ventricle, and volume loading is useful 
for demenstrating the presence of right ventricutar diastolic dysfunction. The 
puq0osa of this study is to evaluate the effects of CMP on dght ventricolar 
diastolic filling during volume loading. Ten adult mongrel dogs weighing 10.9 
.-E 2.4 kg were used in this study. Five dogs were in control group. Rve dogs 
underwent left posterior CMP which was left unstimulated for 2 weeks, and 
followed by chronic stimulation for 8 w~eks. The effects of unstimulated CMP 
on hemodynamius were evaluated by heart catheterization with a Swen-Ganz 
catheter during volume loading (central intravenous infusion of 10 ml/kg of a 
4.5% albumin solution). Cardiac output, LVP, AOP, RVP, PAP, LVEF, RVEF 
was increesed and RVEDP was decreased significantly when con~ared be- 
twean the oardiomyostimulator on and off. After volume loading in contrdi, 
RAP and RVEDP were unohonged, but RVEDV was Increased signiticantly. 
In chmntc adynamic CMP, RAP and RVEDP were increased significantly, but 
RVEDV was not significantly increased. 
Hemedynamics before and after velume loading were as follows: 
RAP RVEDP RVEDV PAP CO 
Conlrol: before 3.64-0.9 2.64-2.1 424-12 30±6.1 2.584-1.3 
after 4.04-1.4 3.2:E 1.3 62-1-22, 37 ~: 5.7" 4.07 ± 1.9" 
CMP: before 3.0:1:1.4 4.24-2.2 554-10 31 ±4.7 2.674-0.3 
alter 6.24-2.3 ° 10±23" 644-6.2 35±2.8 3.25~:0.9 
*p < 0.05 Vs Before. ANOVA 
[Conclusion] CMP may impair the dght ventricular diastolic filling by its 
pericardial constraint during volume loading. 
~ Protelnass Inhibitor Complexes In Cardiogenic 
and Septic Shock 
Ralnhard C. Funck, Wemer Cassel, Helner Blanke, Rainer Seifz, 
Rudolf Egbdng, Bernhard Malsch. D~ of C, ardiology, U. of Marburg, FRG 
In patients (pts) with shock, reduced left ventdcular function and fever it may 
be difficult o exclude septicemia. Therefore we determined the plasma levels 
of the protelnase inhibitor complexes elastase-a 1 proteioane-inh~ltor (ELPI) 
and thrombin-antlthrombio if  (TAT) in 34 pts with cardtoganic shock (CAS) 
and 15 pts with septic shock (SES). 
Methods: ELPI and TAT levels were measuraddudng 4 days after onset 
of 31~ck. Values above the empirically found threshold of 700 pg/I were 
considered to be specific for SES. 
Resu~: ELPI was significantly higher (p < 0,001) in SES (table). Based 
on the 700/zg/I ELPI threshold sensitivity was 0.9C6 in CAS and 0.917 in 
SES. Specificity was 0.917 in CAS and 0.966 in SES. 
Mean ELPI Levels and 95%-confldence Intervals* 
TAOS C AS SES 
4-12 h 411.0 :t: 344.4 pg/l 2384.0:1:444.7 ~g/l' 
12-~4 h 373.4 ~ 356.5 pg/1 1746.5 :b 471.6 ;zg/I 
24--48 h 297.1 =b 385.1/zO/I 1983.4 ~ 421.9 pg/I 
TAOS - time after onset of shock, *normal value: < 200 pg/I 
Conclusion: The : ~-rmination of EI.PI is a nonlnvesive and effective way 
to discriminate CAS and SES. Pts. with ELPI concerttrations > 700 pg/~ are 
YeW likely to suffer from septtcomla. Sensitivity and specificity are excellent. 
TAT levels do not con~bute to the discrimination of CAS and SES, 
~ T h e  Quantitative Analysis of the Coronary 
Perfusion Dudng PTCA With an Astive Perfusion 
selloc~z System 
H~ns R. Flgulla, Markus Ferrari, Jens Wicke, Heindch Krsuzer. Dept. of 
Cardiology, Univers~ of C-~ngen, Germany 
Balloon occlusion of large coronary vessels during PTCA may result in pump 
failure, predominantly in patients with impaired LV-function. To prevent pump 
failure, coronanj assist devices, such as eutoperfusion catheters or low 
profile active pa,'fusion catheters (Corftow TM, Leocor) can be used. Since 
the flow rate of autoperfusion catheter is only 30-50 ml/min and dependent 
on the coronary pressure gradient-- the latter might decrease during PTCA 
in high risk patients - -  a pressure independent active perfus~ons ystem 
might be superior. However, the ques~on mm, a!ne, whether this system is 
able to provide at feast the coronary flow rate during balloon occlusion, that 
can be measured prior to balloon occlusion. In 12 patients with coronary 
vessels supplying lanje amount of myocardium the comnan/flow velocity 
was measured ~ a 0.014" doppler guide wire (RoWe TM) prior to and 
during PTCA with an active parfusion system in the poststenotic vessel The 
coronary flow rote (= average peak flow velocity/2 x vessel uminal area) was 
42.2 ~ 5.1 mVmin prior to PTCA, and during balloon occlusion 55.4:1:19.6 
mVmin. The correlation between the external pump rate and the measured in 
situ values were satisfying (r = 0.91 ). In 11 of 12 pts the poststenotic coronary 
flow rate during balloon occlusion could be adapted to the pre-PTCA vaiue.~. 
The results indc, ate that during PTCA of high risk patients a sufficient 
coronan] perfusion rate can be maintained in the distal vessel with an active 
perfusion system. Thus, this toot reliably provides enough coronary flow to 
prevent pump failure in high risk patients. 
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~ B o n e  Loss in Cardiac Cachectic CHF Patients 
Stefan D. Anker, Tuan Peng Choa, Derek Harrington, Belinda Lees, 
Wolfgang Kox 1, John Stevenson, Philip A. Pcole-Wilsen, Andrew 
J.S. Coats. Irnperlal College and Royal emmpton Hospital, London, UK; 
1 Charitd Bedin, Germany 
Cardiac cachaxla is charactedsed by muscle atrophy. In previous work we 
found the crass-sec~on~l area of the femur in cachectic [c] compared with 
non-cachectic [nc] chronic heart failure [CHF] patients also to be reduced. 
We thereiom assessed total bone mineral deush'y [BMD] and bone miner~ 
content [BMC] by means of dual-energy x-ray absorptiometry in36 noCHF 
(age 59,2 -I- 1.3 y, height 173 -4- 1 cm, mean -~ SE) and 17 cCHF patients 
(62.6:1:2.6 y, 172 :E 1 cm, beth p = NS). Both groups had aimifar MVO= (15.6 
± 1.6 vs 17.2 :t: 1.0 ml/kg/min), LVEF and NYHA class. The cCHF patients 
were grossly almph, ic (all weight loss > 5 kg, body mass index < 24 kg/n~, 
81 ± 2 vs 105:1:2 % ideal weight, p < 0.0001). 
BMD (1.16 :1: 0o02 ~s 1.28 • 0.01 g/cm2, p = 0.01) aad BMC (2677:1:63 vs 
3114:1:58 g, p < 0.0001) were reduced in cCHR BMC was equally reduced 
in arms, legs and trunk of cCHF (all p < 0.001). Overall the reduced BMD 
was correlated with the degree of atrophy (%ideal body weight, r = 0.44, p = 
0.001), serum pllosphate (r = -0.34), TNF-= (r = -0.28) and age (r = -0.28, 
all p < 0.05). The absoluLe loss of bone (BMC) correlated with phosphate 
and TNF-a (both r = -0.34, p = 0.015), cor6sot (r = -0.38) and femoral 
cress-sectional reas (all p < 0.05), but not with age. BMC and BMD were 
not significantly related to either LVER NYHA class or MVO2 (all r < 0.25). 
